Table 1.
Metabolite | Source | Location | Target Cell Lines | Concentration/Effect | Reference |
---|---|---|---|---|---|
lyngbyabellin A (1) | Lyngbya majuscula | Guam | KB cells and LoVo cells | IC50 value of 0.03 and 0.50 µg/mL respectively | [6] |
lyngbyabellin B (2) | Lyngbya majuscula | Guam | KB cells and LoVo cells | IC50 value of 0.10 and 0.83 µg/mL respectively | [10] |
lyngbyabellin E (3) | Lyngbya majuscula | Papua New Guinea | NCI-H460 human lung tumor and neuro-2a mouse neuroblastoma cells | LC50 value of 0.4 and 1.2 µM respectively | [11] |
lyngbyabellin F (4) | Lyngbya majuscula | Papua New Guinea | NCI-H460 human lung tumor and neuro-2a mouse neuroblastoma cells | LC50 value of 1.0 and 1.8 µM respectively | [11] |
lyngbyabellin G (5) | Lyngbya majuscula | Papua New Guinea | NCI-H460 human lung tumor and neuro-2a mouse neuroblastoma cells | LC50 value of 2.2 and 4.8 µM respectively | [11] |
lyngbyabellin H (6) | Lyngbya majuscula | Papua New Guinea | NCI-H460 human lung tumor and neuro-2a mouse neuroblastoma cells | LC50 value of 0.2 and 1.4 µM respectively | [11] |
lyngbyabellin I (7) | Lyngbya majuscula | Papua New Guinea | NCI-H460 human lung tumor and neuro-2a mouse neuroblastoma cells | LC50 value of 1.0 and 0.7 µM respectively | [11] |
lyngbyabellin N (10) | Moorea bouillonii | Palmyra Atoll, USA | H-460 human lung carcinoma and HCT116 colon cancer cell lines | IC50 value of 0.0048–1.8 µM and 15 µM respectively | [12] |
lyngbyaloside B (13) | Lyngbya sp. | Palau | KB cells and LoVo cells | IC50 value of 4.3 and 15 µM respectively | [13] |
2-epi-lyngbyalosid (14) | Lyngbya bouillonii | Apra Harbor, Guam | HT29 colorectal adenocarcinoma and HeLa cells | IC50 value of 38 and 33 µM respectively | [14] |
18E-lyngbyaloside C (15) | Lyngbya bouillonii | Apra Harbor, Guam | HT29 colorectal adenocarcinoma and HeLa cells | IC50 value of 13 and 9.3 µM respectively | [14] |
18Z-lyngbyaloside C (16) | Lyngbya bouillonii | Apra Harbor, Guam | HT29 colorectal adenocarcinoma and HeLa cells | IC50 value of >100 µM and 53 µM respectively | [14] |
biselyngbyaside (17) | Lyngbya sp. | Tokunoshima Island, Japan | HeLa S3 cells | IC50 value of 0.1 μg/mL | [15] |
biselyngbyaside B (18) | Lyngbya sp. | Tokunoshima Island, Japan | HeLa S3 cells and HL60 cells | IC50 value of 3.5 and 0.82 µM respectively | [16] |
biselyngbyaside E (21) | Lyngbya sp. | Ishigaki Island, Japan | HeLa and HL60 cells | IC50 value of 0.19 and 0.071 µM respectively | [17] |
biselyngbyaside F (22) | Lyngbya sp. | Ishigaki Island, Japan | HeLa and HL60 cells | IC50 value of 3.1 and 0.66 µM respectively | [17] |
biselyngbyolide A (23) | Lyngbya sp. | Tokunoshima Island, Japan | HeLa S3 cells and HL60 cells | IC50 value of 0.22 and 0.027 µM respectively | [18] |
biselyngbyolide B (24) | Lyngbya sp. | Ishigaki Island, Japan | HeLa S3 cells and HL60 cells | IC50 value of 0.028 and 0.0027 µM respectively | [19] |
caylobolide A (25) | Lyngbya majuscula | Bahamian | human colon tumor cells HCT 116 | IC50 values of 9.9 µM | [20] |
caylobolide B (26) | Phormidium spp. | Florida USA | HT29 colorectal adenocarcinoma and HeLa cervical carcinoma cells | IC50 value of 4.5 and 12.2 µM respectively | [21] |
swinholide A (27) | Symploca cf. sp. | Fiji | several cancer cell lines | IC50 values of 0.37 nM–1.0 µM | [22] |
ankaraholide A (28) | Geitlerinema sp. | Madagascar | NCI-H460, Neuro-2a cells and MDA-MB-435 cells | IC50 value of 119, 262 and 8.9 nM respectively | [22] |
scytophycin A (30) | Scytonema pseudohofmanni | Oahu, Hawaii | human carcinoma of nasopharynx Cell (KB cells) | IC50 value of 1 ng/mL | [23] |
scytophycin B (31) | Scytonema pseudohofmanni | Oahu, Hawaii | KB cells | IC50 value of 1 ng/mL | [23] |
scytophycins C-E (32–34) | Scytonema pseudohofmanni | Oahu, Hawaii | KB cells | IC50 value of 10–100 ng/mL | [23] |
6-hydroxyscytophycin B (35) | Scytonema mirabile | cultured | KB cells and LoVo cells | MICs of 1–5 and 10–50 ng/mL respectively | [23] |
19-O-demethylscytophycin C (36) | Scytonema burmanicurn | cultured | KB cells and LoVo cells | MICs of 1–5 and 10–50 ng/mL respectively | [23] |
6-hydroxy-7-O-methylscytophycin E (37) | Scytonema ocellatum | cultured | KB cells and LoVo cells | MICs of 1–5 and 10–50 ng/mL respectively | [23] |
tolytoxin (38) | Tolypothrix conglutinata var. colorata | Fanning Island | KB cells and LoVo cells | IC50 value of 8.4 and 5.3 nM respectively | [24] |
debromoaplysiatoxin (39) | Lyngbya majuscula | Marshall Islands | P-388 lymphocytic mouse leukemia | weak | [25] |
lyngbouilloside (44) | Lyngbya bouillonii | Papua New Guinea | neuroblastoma cells | IC50 value of 17 µM | [26] |
koshikalide (45) | Lyngbya sp. | Mie Prefecture | HeLa S3 cells | IC50 value of 42 µg/mL | [27] |
sanctolide A (46) | Oscillatoria sancta | cultured | HT-29 and MDA-MB-435 cell lines | nd a | [28] |
acutiphycin (47) | Oscillatoria acutissima | Manoa Valley Oahu, Hawaii | KB cells and NIH/3T3 cells | ED50 < 1 µg/mL | [29] |
20,21-didehydroacutiphycin (48) | Oscillatoria acutissima | Manoa Valley Oahu, Hawaii | KB cells and NIH/3T3 cells | ED50 < 1 µg/mL | [29] |
polycavernoside D (49) | Okeania sp. | Puerto Rican | H-460 human lung cancer cell lines | EC50 value of 2.5 µM | [30] |
bastimolide A (50) | Okeania hirsuta | Panama | Vero cells | IC50 value of 2.1 µM | [31] |
nuiapolide (51) | colonial cyanobacterium (071905-NII-01) | Hawaii | Jurkat cells and cancerous T lymphocytes | anti-chemotactic activity | [32] |
a Not determined.